Roman Michael F bought ABT
June 30, 2025 · Form 4 insider transaction
Roman Michael F bought 271 shares of Abbott Laboratories at $136.01 per share, a transaction worth $36.9K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
271
Price
$136.01
Total value
$36.9K
InsiderRoman Michael F
RoleDirector
CompanyAbbott Laboratories (ABT)
SecurityStock Equivalent Units
Transaction codeA: Grant or award
Transaction dateJune 30, 2025
Filing dateJuly 1, 2025
Shares owned after5,250
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.; Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.